NCT07532707 2026-04-16
Efficacy of IVIG Versus PLEX in Myasthenic Crisis in Syria.
Damascus University
Phase NA Completed
Clinical Trials
24 trialsNCT06471361 2026-03-27
A Study to Evaluate the Safe and Effective Use of a Zilucoplan Auto-injector by Study Participants With Generalized Myasthenia Gravis
UCB Pharma
Phase 3 Completed
NCT07472777 2026-03-16
Long-term Efficacy of Modified Guilu Erxian Glue for Myasthenia Gravis
Beijing University of Chinese Medicine
Completed
NCT06718855 2026-02-19
MYCOG
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Completed
NCT04818671 2026-01-22
ADAPTSC+
argenx
Phase 3 Completed
NCT06764160 2026-01-15
ECU-MG-304
Alexion Pharmaceuticals, Inc.
Phase 3 Completed
NCT07319689 2026-01-06
Predictors of Myasthenia Gravis Outcome Following Thoracoscopic Thymectomy: Comparative Study Between Thymomatous and Non-Thymomatous Patients
Tanta University
Completed
NCT03971422 2025-12-24
A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis
UCB Pharma
Phase 3 Completed
NCT07291713 2025-12-18
Psychological Health and Adverse Childhood Experiences in Myasthenia Gravis: Online Mental Health BMI Learning Program
Shin Kong Wu Ho-Su Memorial Hospital
Phase NA Completed
NCT05451212 2025-11-10
Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis
Cabaletta Bio
Phase 1 Completed
NCT05681715 2025-11-06
A Phase 3, Open-label, Crossover Study to Evaluate Self-administration of Rozanolixizumab by Study Participants With Generalized Myasthenia Gravis (gMG)
UCB Pharma
Phase 3 Completed
NCT04980495 2025-11-05
ADAPT NXT
argenx
Phase 3 Completed
NCT05230082 2025-09-18
Acupuncture in Myasthenia Gravis (AcuMG)
HealthPartners Institute
Phase NA Completed
NCT04431895 2025-09-16
Safety And Efficacy Of Tofacitinib In Patients With Refractory Myasthenia Gravis: A Pilot Study
Huashan Hospital
Phase EARLY_PHASE1 Completed
NCT07154095 2025-09-04
A Single-Center, Randomized, Open-Label, Two-Sequence, Two-Period, Crossover Study Comparing the Pharmacokinetics and Safety of Pyridostigmine Sustained-Release and Immediate-Release Tablets Following Single and Multiple Doses in Healthy Chinese Participants
West China Second University Hospital
Phase 1 Completed
NCT05514873 2025-09-03
An Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Zilucoplan in Participants With Generalized Myasthenia Gravis Who Were Previously Receiving Intravenous Complement Component 5 Inhibitors
UCB Pharma
Phase 3 Completed
NCT05979688 2025-08-08
Yogic Breathing Exercise for People With Amyotrophic Lateral Sclerosis
University of Alabama at Birmingham
Phase NA Completed
NCT04115293 2025-07-16
RAISE
UCB Pharma
Phase 3 Completed
NCT06158815 2025-07-15
Investigation of the Effects of Proprioceptive Neuromuscular Facilitation Exercises in Patients With Myasthenia Gravis
Hacettepe University
Phase NA Completed
NCT07022028 2025-06-18
GUIMAUVE
Poitiers University Hospital
Completed
NCT03818204 2025-06-13
Clinical Trial to Improve the Magnetic Levator Prosthesis
Massachusetts Eye and Ear Infirmary
Phase NA Completed
NCT05737160 2025-05-23
Study of Telitacicept in Generalized Myasthenia Gravis
RemeGen Co., Ltd.
Phase 3 Completed
NCT04728425 2025-04-27
MG_SCIG
University Health Network, Toronto
Phase 2 Completed
NCT04678115 2025-04-22
Clinical Trial Comparing Two Non-Surgical Treatments for Severe Blepharoptosis
Massachusetts Eye and Ear Infirmary
Phase NA Completed